Latest News

 Filter by Provider

Telehealth company Hims & Hers Health (NYSE:HIMS) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 28.4% year on year to $617.8 million. On the other hand, next quarter’s revenue guidance of $612.5 million was less impressive, coming in 5.6% below analysts’ estimates. Its GAAP profit of $0.08 per share was 92.5% above analysts’ consensus estimates.

Capital One Financial shares are trading lower Monday afternoon as a wave of selling hit U.S. bank and asset-management shares on worries about private credit and AI-exposed lending.

SpaceX aims for “Starship cargo flights to the lunar surface for research, development, and exploratory missions” to start in 2028.

Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales were flat year on year at $209.8 million. The company expects the full year’s revenue to be around $870 million, close to analysts’ estimates. Its non-GAAP profit of $0.04 per share was significantly above analysts’ consensus estimates.

IBM stock sold off suddenly and sharply Monday as the tech giant became the latest victim to investor fears about Anthropic's AI code.

Online insurance comparison site EverQuote (NASDAQ:EVER) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 32.5% year on year to $195.3 million. On the other hand, next quarter’s revenue guidance of $180 million was less impressive, coming in 7% below analysts’ estimates. Its GAAP profit of $1.54 per share was significantly above analysts’ consensus estimates.

Global X Canadian Oil and Gas Equity Covered Call ETF (TSX:ENCC) is a covered call ETF income investors should know about.

Canadian REIT ETFs pay high but tax-inefficient yields, so a TFSA is the best place to hold them.

These two growth stocks are top buys.

American Express stock led the Dow Jones Industrial Average lower as markets gave credence to Citrini Research's 2027 AI recession scenario.

Digital payment platform Paymentus (NYSE:PAY) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 28.1% year on year to $330.5 million. The company expects next quarter’s revenue to be around $335 million, coming in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.20 per share was 22.9% above analysts’ consensus estimates.

AI disruption fears are leading to indiscriminate sell-offs in specific stocks.

The data center development across Caddo and Bossier Parishes will create 540 full-time jobs, the company said.

A large clinical trial of the company's cancer screening test did not produce the desired result.

Specialty insurance provider Skyward Specialty Insurance (NASDAQ:SKWD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 26.7% year on year to $385.6 million. Its non-GAAP profit of $1.17 per share was 14.9% above analysts’ consensus estimates.

JPMorgan Chase shares are sharply lower Monday afternoon, falling as investors dumped financials amid a broad sell-off tied to mounting worries over private credit and AI-linked credit risks.

While Super Micro Computer got caught amid recent tariff-related anxieties, the smart money seems relatively confident about SMCI stock.

Theater company AMC Entertainment (NYSE:AMC) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $1.29 billion. Its non-GAAP loss of $0.18 per share was 28% above analysts’ consensus estimates.

Here's why this high-quality ETF, offering a yield of 5.6%, is one of the best investments you can buy for passive income.

This healthcare REIT’s monthly payout looks more supported than it was a year ago, but refinancing and leverage still matter.

A 5% drop in the crypto sector's most important token is a big deal.

Emerging markets are outperforming U.S. stocks by 13 percentage points in two months — the biggest relative surge since 2008.